Response to Letter of Stephenson et al.: Nardilysin: A potential biomarker for the early diagnosis of acute coronary syndrome

Int J Cardiol. 2019 Feb 15:277:249. doi: 10.1016/j.ijcard.2018.10.022.

Authors

Mikiko Ohno¹, Po-Min Chen², Takeshi Kimura³, Eiichiro Nishi⁴

Affiliations

¹ Department of Pharmacology, Shiga University of Medical Science, Otsu, Japan.
² Department of Cardiovascular Medicine, Saiseikai Noe Hospital, Osaka, Japan.
³ Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁴ Department of Pharmacology, Shiga University of Medical Science, Otsu, Japan. Electronic address: [email protected].

PMID: 30661548
DOI: 10.1016/j.ijcard.2018.10.022

No abstract available

Keywords: Acute coronary syndrome; Biomarker; Platelet.

Publication types

Letter
Comment

MeSH terms

Acute Coronary Syndrome*
Biomarkers
Early Diagnosis
Humans
Metalloendopeptidases

Substances

Biomarkers
Metalloendopeptidases
nardilysin